BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 16831965)

  • 1. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
    Pittock SJ; Weinshenker BG; Lucchinetti CF; Wingerchuk DM; Corboy JR; Lennon VA
    Arch Neurol; 2006 Jul; 63(7):964-8. PubMed ID: 16831965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
    Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
    Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
    Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.
    Takahashi T; Fujihara K; Nakashima I; Misu T; Miyazawa I; Nakamura M; Watanabe S; Shiga Y; Kanaoka C; Fujimori J; Sato S; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1235-43. PubMed ID: 17449477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain abnormalities in neuromyelitis optica.
    Pittock SJ; Lennon VA; Krecke K; Wingerchuk DM; Lucchinetti CF; Weinshenker BG
    Arch Neurol; 2006 Mar; 63(3):390-6. PubMed ID: 16533966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica.
    Hinson SR; Pittock SJ; Lucchinetti CF; Roemer SF; Fryer JP; Kryzer TJ; Lennon VA
    Neurology; 2007 Dec; 69(24):2221-31. PubMed ID: 17928579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica.
    Min JH; Kim HJ; Kim BJ; Lee KW; Sunwoo IN; Kim SM; Kim BJ; Kim SH; Park MS; Waters P; Vincent A; Sung JJ; Lee KH
    Mult Scler; 2009 Sep; 15(9):1069-76. PubMed ID: 19625331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
    Misu T; Fujihara K; Itoyama Y
    Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [AQP4 immunohistochemistry in neuromyelitis optica and multiple sclerosis: a neuropathological review].
    Yoshida M
    Brain Nerve; 2010 Sep; 62(9):961-74. PubMed ID: 20844307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute disseminating encephalomyelitis in neuromyelitis optica: closing the floodgates.
    Eichel R; Meiner Z; Abramsky O; Gotkine M
    Arch Neurol; 2008 Feb; 65(2):267-71. PubMed ID: 18268199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica.
    Cayrol R; Saikali P; Vincent T
    Ann N Y Acad Sci; 2009 Sep; 1173():478-86. PubMed ID: 19758189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.
    Fazio R; Malosio ML; Lampasona V; De Feo D; Privitera D; Marnetto F; Centonze D; Ghezzi A; Comi G; Furlan R; Martino G
    Mult Scler; 2009 Oct; 15(10):1153-63. PubMed ID: 19667009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies.
    Nicchia GP; Mastrototaro M; Rossi A; Pisani F; Tortorella C; Ruggieri M; Lia A; Trojano M; Frigeri A; Svelto M
    Glia; 2009 Oct; 57(13):1363-73. PubMed ID: 19229993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica.
    Ito S; Mori M; Makino T; Hayakawa S; Kuwabara S
    Ann Neurol; 2009 Sep; 66(3):425-8. PubMed ID: 19798642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features of NMO according to brain MRI findings].
    Shimizu Y
    Brain Nerve; 2010 Sep; 62(9):933-43. PubMed ID: 20844304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromyelitis optica IgG status in acute partial transverse myelitis.
    Scott TF; Kassab SL; Pittock SJ
    Arch Neurol; 2006 Oct; 63(10):1398-400. PubMed ID: 17030654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aquaporin-4 autoantibodies in a paraneoplastic context.
    Pittock SJ; Lennon VA
    Arch Neurol; 2008 May; 65(5):629-32. PubMed ID: 18474738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
    Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
    Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders.
    MagaƱa SM; Matiello M; Pittock SJ; McKeon A; Lennon VA; Rabinstein AA; Shuster E; Kantarci OH; Lucchinetti CF; Weinshenker BG
    Neurology; 2009 Feb; 72(8):712-7. PubMed ID: 19237699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.